Andrew Chen

Andrew Chen is an experienced finance professional currently serving in Corporate Development at Bora Pharmaceuticals, focusing on mergers and acquisitions, investments, and strategy since March 2024. Prior to this role, Andrew gained expertise at PwC in Financial Markets & Business Advisory with a focus on private equity and venture capital valuation, and at Deloitte in Financial Advisory, specializing in valuation modeling, restructuring advisory, and M&A. Andrew began a career in investment with Capital Investment Trust Corp and gained experience in equity research at ROTH Capital Partners, covering cleantech and solar sectors. Academic credentials include a Bachelor's Degree in Accounting and Business Administration from the University of Southern California, as well as a World Bachelor in Business from The Hong Kong University of Science and Technology. Early education was completed at Suffield Academy and Eaglebrook School.